189 related articles for article (PubMed ID: 25634539)
21. Glutathione transferase-M2-2 secreted from glioblastoma cell protects SH-SY5Y cells from aminochrome neurotoxicity.
Cuevas C; Huenchuguala S; Muñoz P; Villa M; Paris I; Mannervik B; Segura-Aguilar J
Neurotox Res; 2015 Apr; 27(3):217-28. PubMed ID: 25403520
[TBL] [Abstract][Full Text] [Related]
22. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
[TBL] [Abstract][Full Text] [Related]
23. Aminochrome as a preclinical experimental model to study degeneration of dopaminergic neurons in Parkinson's disease.
Paris I; Cardenas S; Lozano J; Perez-Pastene C; Graumann R; Riveros A; Caviedes P; Segura-Aguilar J
Neurotox Res; 2007 Sep; 12(2):125-34. PubMed ID: 17967736
[TBL] [Abstract][Full Text] [Related]
24. The Importance of Mitophagy in Maintaining Mitochondrial Function in U373MG Cells. Bafilomycin A1 Restores Aminochrome-Induced Mitochondrial Damage.
Huenchuguala S; Muñoz P; Segura-Aguilar J
ACS Chem Neurosci; 2017 Oct; 8(10):2247-2253. PubMed ID: 28763613
[TBL] [Abstract][Full Text] [Related]
25. Stabilization of Alpha-Synuclein Oligomers In Vitro by the Neurotransmitters, Dopamine and Norepinephrine: The Effect of Oxidized Catecholamines.
Fischer AF; Matera KM
Neurochem Res; 2015 Jul; 40(7):1341-9. PubMed ID: 25956992
[TBL] [Abstract][Full Text] [Related]
26. An alternatively spliced form of NQO1 (DT-diaphorase) messenger RNA lacking the putative quinone substrate binding site is present in human normal and tumor tissues.
Gasdaska PY; Fisher H; Powis G
Cancer Res; 1995 Jun; 55(12):2542-7. PubMed ID: 7780966
[TBL] [Abstract][Full Text] [Related]
27. Dopamine-dependent iron toxicity in cells derived from rat hypothalamus.
Paris I; Martinez-Alvarado P; Cárdenas S; Perez-Pastene C; Graumann R; Fuentes P; Olea-Azar C; Caviedes P; Segura-Aguilar J
Chem Res Toxicol; 2005 Mar; 18(3):415-9. PubMed ID: 15777081
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of NQO1 protects human SK-N-MC neuroblastoma cells against dopamine-induced cell death.
Zafar KS; Inayat-Hussain SH; Siegel D; Bao A; Shieh B; Ross D
Toxicol Lett; 2006 Oct; 166(3):261-7. PubMed ID: 16978807
[TBL] [Abstract][Full Text] [Related]
29. Molecular and neurochemical mechanisms in PD pathogenesis.
Paris I; Lozano J; Perez-Pastene C; Muñoz P; Segura-Aguilar J
Neurotox Res; 2009 Oct; 16(3):271-9. PubMed ID: 19526278
[TBL] [Abstract][Full Text] [Related]
30. Copper dopamine complex induces mitochondrial autophagy preceding caspase-independent apoptotic cell death.
Paris I; Perez-Pastene C; Couve E; Caviedes P; LeDoux S; Segura-Aguilar J
J Biol Chem; 2009 May; 284(20):13306-13315. PubMed ID: 19265190
[TBL] [Abstract][Full Text] [Related]
31. Effects of intravenous immunoglobulin on alpha synuclein aggregation and neurotoxicity.
Smith LM; Klaver AC; Coffey MP; Dang L; Loeffler DA
Int Immunopharmacol; 2012 Dec; 14(4):550-7. PubMed ID: 23026444
[TBL] [Abstract][Full Text] [Related]
32. Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells.
Yamakawa K; Izumi Y; Takeuchi H; Yamamoto N; Kume T; Akaike A; Takahashi R; Shimohama S; Sawada H
Biochem Biophys Res Commun; 2010 Jan; 391(1):129-34. PubMed ID: 19900407
[TBL] [Abstract][Full Text] [Related]
33. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.
Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Toxicol Sci; 2015 Feb; 143(2):454-68. PubMed ID: 25416158
[TBL] [Abstract][Full Text] [Related]
34. Glutathione transferase mu 2 protects glioblastoma cells against aminochrome toxicity by preventing autophagy and lysosome dysfunction.
Huenchuguala S; Muñoz P; Zavala P; Villa M; Cuevas C; Ahumada U; Graumann R; Nore BF; Couve E; Mannervik B; Paris I; Segura-Aguilar J
Autophagy; 2014 Apr; 10(4):618-30. PubMed ID: 24434817
[TBL] [Abstract][Full Text] [Related]
35. α-Synuclein oligomers distinctively permeabilize complex model membranes.
Stefanovic AN; Stöckl MT; Claessens MM; Subramaniam V
FEBS J; 2014 Jun; 281(12):2838-50. PubMed ID: 24767583
[TBL] [Abstract][Full Text] [Related]
36. Dopamine in Parkinson's disease.
Latif S; Jahangeer M; Maknoon Razia D; Ashiq M; Ghaffar A; Akram M; El Allam A; Bouyahya A; Garipova L; Ali Shariati M; Thiruvengadam M; Azam Ansari M
Clin Chim Acta; 2021 Nov; 522():114-126. PubMed ID: 34389279
[TBL] [Abstract][Full Text] [Related]
37. Regulation of α-synuclein expression in cultured cortical neurons.
Clough RL; Dermentzaki G; Haritou M; Petsakou A; Stefanis L
J Neurochem; 2011 Apr; 117(2):275-85. PubMed ID: 21272005
[TBL] [Abstract][Full Text] [Related]
38. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein.
Rutherford NJ; Moore BD; Golde TE; Giasson BI
J Neurochem; 2014 Dec; 131(6):859-67. PubMed ID: 24984882
[TBL] [Abstract][Full Text] [Related]
39. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
40. Inducible over-expression of wild type alpha-synuclein in human neuronal cells leads to caspase-dependent non-apoptotic death.
Vekrellis K; Xilouri M; Emmanouilidou E; Stefanis L
J Neurochem; 2009 Jun; 109(5):1348-62. PubMed ID: 19476547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
